Italia markets open in 2 hours 43 minutes

Boston Scientific Corporation (BSX)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
67,42-0,54 (-0,79%)
Alla chiusura: 04:00PM EDT
67,95 +0,53 (+0,79%)
Dopo ore: 07:59PM EDT

Boston Scientific Corporation

300 Boston Scientific Way
Marlborough, MA 01752-1234
United States
508 683 4000
https://www.bostonscientific.com

Settore/iHealthcare
SettoreMedical Devices
Impiegati a tempo pieno48.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Michael F. MahoneyChairman, President & CEO4,83M12,98M1965
Mr. Daniel J. BrennanExecutive VP & CFO2,15M1,71M1966
Mr. Joseph M. FitzgeraldExecutive VP & Group President of Cardiology1,84M4,7M1964
Mr. Jeffrey B. MirvissExecutive VP & President of Peripheral Interventions1,44MN/D1966
Mr. Arthur Crosswell ButcherExecutive VP and Group President of MedSurg & Asia Pacific1,49M626,04k1971
Mr. David J. RouxIndependent Director135kN/D1957
Mr. John Bradley SorensonExecutive Vice President of Global OperationsN/DN/D1968
Ms. Emily WoodworthSenior VP, Global Controller & Chief Accounting OfficerN/DN/D1978
Ms. Jodi Euerle EddySenior VP and Chief Information & Digital OfficerN/DN/D1974
Mr. Jonathan R MonsonSenior VP of Investor RelationsN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Governance aziendale

L'ISS Governance QualityScore di Boston Scientific Corporation al 1 aprile 2024 è 9. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 9; diritti degli azionisti: 8; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.